Insilico Rises, Hygon Dips, AOU Gains

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- InSilico Medicine has nominated ISM1354, a next-generation small molecule GIPR antagonist, as a preclinical candidate for potential intervention of obesity and related disorders including type 2 diabetes, according to an HKEX filing.
- Hygon and Chinese tech hardware hardware stocks are down following a continued sell off ahead of China's long holiday as the prospect of competition from lower tier chips rattles investors.
- Taiwanese chipmakers are in a much healthier place as the build out of agentic AI and a strong US chip trading session lifts stocks outside TSMC. A new developing theme is glass substrate that lifts Taiwan plays such as AOU and Innolux.

See omnystudio.com/listener for privacy information.